Meta Earnings Call: AI Improves UX For Over 3 Billion People
How is AI transforming user experience in Meta's platforms? Find out in the Q2 earnings call that highlights increased growth and engagement.
Source: searchenginejournal.com
📰 Discovery Engine News
Page 4 - Discovery Engine News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Discovery Engine. Real-time updates on events, politics, business and more.
Immunome Surges On News Of Merger With Morphimmune
Shares of biopharmaceutical company Immunome, Inc. (IMNM) are rising more than 36% Thursday morning after announcing merger with Morphimmune, a private biotechnology company in an all-stock transaction.
Clayb Siegall Redmile Group Immunome Inc Enavate Sciences Targeted Effector Platform Discovery Engine
Source: rttnews.com
Immunome Surges On News Of Merger With Morphimmune
Shares of biopharmaceutical company Immunome, Inc. (IMNM) are rising more than 36% Thursday morning after announcing merger with Morphimmune, a private biotechnology company in an all-stock transaction.
Clayb Siegall Redmile Group Immunome Inc Enavate Sciences Targeted Effector Platform Discovery Engine
Source: rttnews.com
Arvinas Announces Changes to its Board of Directors
NEW HAVEN, Conn., June 15, 2023 -- Arvinas, Inc. , a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that Timothy Shannon,... | June 15, 2023
Source: marketscreener.com
Arvinas to Participate in Upcoming Investor Conferences
05.06.2023 - NEW HAVEN, Conn., June 05, 2023 (GLOBE NEWSWIRE) - Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will participate in two ...
Jeff Boyle Arvinas Inc Goldman Sachs Healthcare Conference Annual Global Healthcare Conference Discovery Engine
Source: wallstreet-online.de
Immunome Publishes Preclinical Research Demonstrating that Inhibition of IL-38 Using an Antibody Leads to Anti-Tumor Activity
Immunome, Inc. , a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop antibody therapeutics to improve patient care, today announced the... | May 23, 2023
Matthew Robinson Purnanand Sarma Immunome Inc Chief Technology Officer Discovery Engine Chief Executive Officer
Source: marketscreener.com
Immunome Reports First Quarter 2023 Financial Results
Immunome, Inc. , a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics to improve patient care, today reported... | May 5, 2023
Source: marketscreener.com
Arvinas Reports First Quarter 2023 Financial Results and Provides Corporate Update
–Multiple vepdegestrant studies enrolling globally, including Phase 1, 2, and 3 studies– – Preliminary data from the Phase 1b combination trial of vepdegestrant + palbociclib... | May 5, 2023
Source: marketscreener.com
Arvinas to Present at the Bank of America Securities 2023
NEW HAVEN, Conn., May 03, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs...
Source: globenewswire.com
Arvinas to Present at Stifel Targeted Oncology Day
NEW HAVEN, Conn., April 21, 2023 -- Arvinas, Inc. , a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that Ian Taylor,... | April 21, 2023
Source: marketscreener.com